AAAAAA

   
Results: 1-9 |
Results: 9
Long-term results of a randomized study comparing three immunosuppressive schedules with cyclosporine in cadaveric kidney transplantation
Authors: Montagnino, G Tarantino, A Segoloni, GP Cambi, V Rizzo, G Altieri, P Castagneto, M Salvadori, M Cossu, M Pisani, F Carmellini, M Mastrangelo, F Ferrara, R Ponticelli, C
Citation: G. Montagnino et al., Long-term results of a randomized study comparing three immunosuppressive schedules with cyclosporine in cadaveric kidney transplantation, J AM S NEPH, 12(10), 2001, pp. 2163-2169
Long-term survival of patients with renal transplantation in Fabry's disease
Authors: Mignani, R Gerra, D Maldini, L Bignardi, L Casanova, S Cambi, V Cagnoli, L
Citation: R. Mignani et al., Long-term survival of patients with renal transplantation in Fabry's disease, CONTR NEPHR, 136, 2001, pp. 229-233
Basiliximab significantly reduces acute rejection in renal transplant patients given triple therapy with azathioprine
Authors: Ponticelli, C Yussim, A Cambi, V Legendre, C Rizzo, G Salvadori, M Kahn, D Kashi, SH Salmela, K Fricke, L Garcia-Martinez, J Lechler, R Heemann, U Monteon, F Ortuno, J Amenabar, JJ Arias, M Nicholson, ML Sperschneider, H Abendroth, D Gracida, C Lao, M Sever, MS Lameire, N Sanchez-Fructuoso, A Basci, A Segoloni, G Connolly, J Altieri, P Akoh, J Prestele, H Girault, D
Citation: C. Ponticelli et al., Basiliximab significantly reduces acute rejection in renal transplant patients given triple therapy with azathioprine, TRANSPLAN P, 33(1-2), 2001, pp. 1009-1010
A randomized, double-blind trial of basiliximab immunoprophylaxis plus triple therapy in kidney transplant recipients
Authors: Ponticelli, C Yussim, A Cambi, V Legendre, C Rizzo, G Salvadori, M Kahn, D Kashi, H Salmela, K Fricke, L Heemann, U Garcia-Martinez, J Lechler, R Prestele, H Girault, D
Citation: C. Ponticelli et al., A randomized, double-blind trial of basiliximab immunoprophylaxis plus triple therapy in kidney transplant recipients, TRANSPLANT, 72(7), 2001, pp. 1261-1267
Progress in dialysis technology: membrane selection and patient outcome
Authors: Locatelli, F Valderrabano, F Hoenich, N Bommer, J Leunissen, K Cambi, V
Citation: F. Locatelli et al., Progress in dialysis technology: membrane selection and patient outcome, NEPH DIAL T, 15(8), 2000, pp. 1133-1139
The management of chronic renal insufficiency in the conservative phase
Authors: Locatelli, F Valderrabano, F Hoenich, N Bommer, J Leunissen, K Cambi, V
Citation: F. Locatelli et al., The management of chronic renal insufficiency in the conservative phase, NEPH DIAL T, 15(10), 2000, pp. 1529-1534
High-efficiency dialysis with PMMA dialyzers: Treatment dose delivery and long-term results
Authors: David, S Cambi, V
Citation: S. David et V. Cambi, High-efficiency dialysis with PMMA dialyzers: Treatment dose delivery and long-term results, CONTR NEPHR, 125, 1999, pp. 96-110
Interleukin-12 is synthesized by mesangial cells and stimulates platelet-activating factor synthesis, cytoskeletal reorganization, and cell shape change
Authors: Bussolati, B Mariano, F Biancone, L Foa, R David, S Cambi, V Camussi, G
Citation: B. Bussolati et al., Interleukin-12 is synthesized by mesangial cells and stimulates platelet-activating factor synthesis, cytoskeletal reorganization, and cell shape change, AM J PATH, 154(2), 1999, pp. 623-632
Epidemiology and demography of treated end-stage renal failure in the elderly: from the European Renal Association (ERA-EDTA) Registry
Authors: Berthoux, F Gellert, R Jones, E Mendel, S Valderrabano, F Briggs, D Carrera, F Cambi, V Saker, L
Citation: F. Berthoux et al., Epidemiology and demography of treated end-stage renal failure in the elderly: from the European Renal Association (ERA-EDTA) Registry, NEPH DIAL T, 13, 1998, pp. 65-68
Risultati: 1-9 |